EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A machine learning approach in a monocentric cohort for predicting primary refractory disease in Diffuse Large B-cell lymphoma patients

Marie Y Detrait iD, Stéphanie Warnon, Raphaël Lagasse, Laurent Dumont, Stéphanie De Prophétis, Amandine Hansenne, Juliette Raedemaeker, Valérie Robin, Géraldine Verstraete, Aline Gillain, Nicolas Depasse, Pierre Jacmin und 1 weitere

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0311261 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Marie Y Detrait und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Technology and Information Systems, Grand Hôpital de Charleroi, Charleroi, Belgium. Hauptthemen laut MEDLINE: Lymphoma, Large B-Cell, Diffuse, Machine Learning. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Primary refractory disease affects 30–40% of patients diagnosed with DLBCL and is a significant challenge in disease management due to its poor prognosis. Predicting refractory status could greatly inform treatment strategies, enabling early intervention. Various options are now available based on patient and disease characteristics. Supervised machine-learning techniques, which can predict outcomes in a medical context, appear highly suitable for this purpose.

Design

Retrospective monocentric cohort study. Patient population Adult patients with a first diagnosis of DLBCL admitted to the hematology unit from 2017 to 2022.

Aim

We evaluated in our Center five supervised machine-learning (ML) models as a tool for the prediction of primary refractory DLBCL. Main results One hundred and thirty patients with Diffuse Large B-cell lymphoma (DLBCL) were included in this study between January 2017 and December 2022. The variables used for analysis included demographic characteristics, clinical condition, disease characteristics, first-line therapy and PET-CT scan realization after 2 cycles of treatment. We compared five supervised ML models: support vector machine (SVM), Random Forest Classifier (RFC), Logistic Regression (LR), Naïve Bayes (NB) Categorical classifier and eXtreme Gradient Boost (XGboost), to predict primary refractory disease. The performance of these models was evaluated using the area under the receiver operating characteristic curve (ROC-AUC), accuracy, false positive rate, sensitivity, and F1-score to identify the best model. After a median follow-up of 19.5 months, the overall survival rate was 60% in the cohort. The Overall Survival at 3 years was 58.5% (95%CI, 51–68.5) and the 3-years Progression Free Survival was 63% (95%CI, 54–71) using Kaplan-Meier method. Of the 124 patients who received a first line treatment, primary refractory disease occurred in 42 patients (33.8%) and 2 patients (1.6%) experienced relapse within 6 months. The univariate analysis on refractory disease status shows age (p = 0.009), Ann Arbor stage (p = 0.013), CMV infection (p = 0.012), comorbidity (p = 0.019), IPI score (p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphoma, Large B-Cell, DiffuseMachine LearningHumansMaleFemaleMiddle AgedAgedRetrospective StudiesAdultPrognosisAged, 80 and overSupport Vector MachineROC CurveCohort StudiesPositron Emission Tomography Computed Tomography

Autor:innen und Institutionen

  • Department of Technology and Information Systems, Grand Hôpital de Charleroi, Charleroi, Belgium.
  • Department of Clinical Research, Grand Hôpital de Charleroi, Charleroi, Belgium.
  • Department of Medico-Economic Information, Grand Hôpital de Charleroi, Charleroi, Belgium.
  • School of Public Health, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium.
  • Division of Hematology, Hematology and oncology Department, Grand Hôpital de Charleroi, Charleroi, Belgium.

ORCID-Profile: Marie Y Detrait

Zitieren

APA

Detrait, M. Y., Warnon, S., Lagasse, R., Dumont, L., De Prophétis, S., Hansenne, A., Raedemaeker, J., Robin, V., Verstraete, G., Gillain, A., Depasse, N., Jacmin, P., & Pranger, D. (2024). A machine learning approach in a monocentric cohort for predicting primary refractory disease in Diffuse Large B-cell lymphoma patients. PLOS ONE. https://doi.org/10.1371/journal.pone.0311261

Vancouver

Detrait MY, Warnon S, Lagasse R, Dumont L, De Prophétis S, Hansenne A, et al. A machine learning approach in a monocentric cohort for predicting primary refractory disease in Diffuse Large B-cell lymphoma patients. PLOS ONE. 2024. doi:10.1371/journal.pone.0311261

BibTeX
@article{Detrait2024,
  author = {Detrait, Marie Y and Warnon, Stéphanie and Lagasse, Raphaël and Dumont, Laurent and De Prophétis, Stéphanie and Hansenne, Amandine and Raedemaeker, Juliette and Robin, Valérie and Verstraete, Géraldine and Gillain, Aline and Depasse, Nicolas and Jacmin, Pierre and Pranger, Delphine},
  title = {A machine learning approach in a monocentric cohort for predicting primary refractory disease in Diffuse Large B-cell lymphoma patients},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0311261}
}
Kostenlos starten →